CAS 1217049-32-5

GYKI-47261 dihydrochloride

CAS: 1217049-32-5

GYKI-47261 dihydrochloride

Reinheit: ≥98%

Molekulargewicht: 395.71g/mol

Ref: 54-BUP21195

GYKI-47261 dihydrochloride

CAS: 1217049-32-5

GYKI-47261 dihydrochloride is an AMPA receptor antagonist and CYP2E1 inducer, demonstrating broad-spectrum anticonvulsant and neuroprotective activities.

Formel: C₁₈H₁₇Cl₃N₄

Reinheit: 98.32% - 99.14%

Farbe und Form: Solid

Molekulargewicht: 395.71

Ref: TM-T38601

Gyki 47261 dihydrochloride

CAS: 1217049-32-5

Gyki 47261 dihydrochloride is a combination therapy for Alzheimer's disease that blocks the NMDA receptor and inhibits nerve agents. It is an organophosphate, which are inhibitors of amyloid precursor protein (APP) and have been shown to inhibit the production of beta-amyloid peptides in a variety of cell types. They bind to the active site of acetylcholinesterase and are competitive inhibitors with high affinity for this enzyme. This drug has also been shown to act as an antagonist at benzodiazepine receptors, which may be responsible for its effects on neurosteroids. Gyki 47261 dihydrochloride has also been shown to be a neurosteroid receptor blocker and has some effect on nerve cells.

Formel: C₁₈H₁₇Cl₃N₄

Reinheit: Min. 95%

Molekulargewicht: 395.7 g/mol

Ref: 3D-SYB04932